Stay updated on SPN-812 Safety/Efficacy in Adult ADHD: Clinical Trial
Sign up to get notified when there's something new on the SPN-812 Safety/Efficacy in Adult ADHD: Clinical Trial page.

Latest updates to the SPN-812 Safety/Efficacy in Adult ADHD: Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. The study content, eligibility criteria, and results remain unchanged.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now consolidates study locations under a single Locations section listing Florida, Illinois, Kentucky, and Virginia; separate location sections/pages for these states have been removed.SummaryDifference0.6%

- Check52 days agoChange DetectedAdded Revision: v3.3.2 and removed Revision: v3.2.0 from the page.SummaryDifference0.1%

- Check59 days agoChange DetectedDeleted the site-wide notice about government funding and potential data currency. The study-specific information on the page remains unchanged.SummaryDifference0.4%

- Check81 days agoChange DetectedResults for the study have been posted. The page now shows 'Results First Posted 2024-10-15' and related submission dates in the Study Record Dates.SummaryDifference0.5%

- Check103 days agoChange DetectedUpdated page to reflect a new version (v3.2.0) and a crucial operating-status notice about potential delays due to funding, clarifying that the NIH Clinical Center is open and where to verify status.SummaryDifference3%

Stay in the know with updates to SPN-812 Safety/Efficacy in Adult ADHD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPN-812 Safety/Efficacy in Adult ADHD: Clinical Trial page.